Contrast-enhanced MR imaging

Hamm, 1992, Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients, Radiology, 182, 167, 10.1148/radiology.182.1.1309218 Hamm, 1995, Phase I clinical evaluation of GD-EOB-DTPA as a hepatobiliary contrast agent: safety, pharmacokinetics, and MR imaging, Radiology, 195, 785, 10.1148/radiology.195.3.7754011 Vogl, 1992, Gadobenate dimeglumine—a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers, American Journal of Roentgenology, 158, 887, 10.2214/ajr.158.4.1546612 Weissleder, 1994, Liver MR imaging with iron oxides: toward consensus and clinical practice, Radiology, 193, 593, 10.1148/radiology.193.3.7972790 Saini, 1995, Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227), American Journal of Roentgenology, 164, 1147, 10.2214/ajr.164.5.7717222 Marti-Bonmati, 1991, High density barium sulphate as an oral contrast, Magnetic Resonance Imaging, 9, 259, 10.1016/0730-725X(91)90019-I Ros, 1991, The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers, American Journal of Roentgenology, 157, 761, 10.2214/ajr.157.4.1892032 Brown, 1991, Perfluroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon, Radiology, 181, 455, 10.1148/radiology.181.2.1924788 Mattrey, 1991, Results of the phase III trials with Imagent® GI as an oral magnetic resonance contrast agent, Investigative Radiology, 26, S65, 10.1097/00004424-199111001-00021 MacVicar, 1993, Phase III trial of oral magnetic particles in MRI of abdomen and pelvis, Clinical Radiology, 47, 183, 10.1016/S0009-9260(05)81159-6 Laniado, 1988, MR imaging of the gastrointestinal tract: value of Gd-DTPA, American Journal of Roentgenology, 150, 817, 10.2214/ajr.150.4.817 Kaminsky, 1991, Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy, Radiology, 178, 503, 10.1148/radiology.178.2.1987615 Hasso, 1993, Current status of enhanced magnetic resonance imaging in neuroradiology, Investigative Radiology, 28, S3, 10.1097/00004424-199303001-00002 Russel, 1989, Multicenter double blind placebo-controlled study of gadopentate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions, American Journal of Roentgenology, 10, 813, 10.2214/ajr.152.4.813 Majumdar, 1988, Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents, Magnetic Resonance Imaging, 6, 611, 10.1016/0730-725X(88)90082-3 Warach, 1992, Acute cerebral ischemia: Evaluation with dynamic contrast-enhanced MR imaging and MR angiography, Radiology, 182, 41, 10.1148/radiology.182.1.1727307 Runge, 1993, Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced steady-state free precession MR imaging: an animal study, American Journal of Roentgenology, 160, 593, 10.2214/ajr.160.3.8430562 Rosen, 1991, Susceptibility contrast imaging of cerebral blood volume: Human experience, Magnetic Resonance in Medicine, 22, 293, 10.1002/mrm.1910220227 Schörner, 1986, Time dependent changes in image contrast in brain tumours after Gadolinium-DTPA, American Journal of Neuroradiology, 7, 1013 Haustein, 1993, Triple-dose versus standard-dose gadopentate dimeglumine: A randomised study in 199 patients, Radiology, 186, 855, 10.1148/radiology.186.3.8430199 Mehta, 1995, Central nervous system tumor, infection and infarction: Detection with gadolinium-enhanced magnetization transfer MR imaging, Radiology, 195, 41, 10.1148/radiology.195.1.7892492 Nelson, 1993, Primary neoplasms and postoperative/postradiation changes in the brain, 23 Fulbright, 1993, Secondary neoplams and meningeal disease, 101 Valk, 1991, Diagnostic imaging of central nervous system radiation injury, 211 Davis, 1991, Diagnosis of cerebral metastases; double-dose delayed CT versus contrast-enhanced MR imaging, American Journal of Neuroradiology, 12, 293 Sze, 1990, Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT, American Journal of Neuroradiology, 11, 785 Elster, 1990, Early cerebral infarction: gadopentetate dimeglumine enhancement, Radiology, 177, 627, 10.1148/radiology.177.3.2243961 Elster, 1991, MR contrast enhancement in brainstem and deep cerebral infarction, American Journal of Neuroradiology, 12, 1127 Crain, 1991, Cerebral ischemia: evaluation with contrast-enhanced MR imaging, American Journal of Neuroradiology, 12, 631 Fernandez, 1990, Lyme disease of the CNS: MR imaging findings in 14 cases, American Journal of Neuroradiology, 11, 479 Grossman, 1988, Multiple sclerosis: serial study of gadolinium-enhanced MR imaging, Radiology, 169, 117, 10.1148/radiology.169.1.3420246 Chang, 1990, Gadolinium-DTPA-enhanced MR imaging of the brain in patients with meningitis: comparison with CT, American Journal of Neuroradiology, 11, 69 Tsuchiya, 1992, Contrast-enhanced magnetic resonance imaging of sub- and epidural empyemas, Neuroradiology, 34, 494, 10.1007/BF00598958 Seltzer, 1991, CNS sarcoidosis: evaluation with contrast-enhanced MR imaging, American Journal of Neuroradiology, 12, 1227 Sze, 1989, MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis, American Journal of Neuroradiology, 10, 965 Burke, 1990, Meninges: Benign postoperative enhancement on MR images, Radiology, 174, 99, 10.1148/radiology.174.1.2294579 Kucharczyk, 1991, The Sella and Parasellar Region, 625 Simon, 1988, Fat suppression MR imaging of the orbit, American Journal of Neuroradiology, 9, 961 Tien, 1991, Intra- and paraorbital lesions: value of fat suppression MR imaging with paramagnetic contrast enhancement, American Journal of Neuroradiology, 12, 245 Hendrix, 1990, MR imaging of optic nerve lesions: value of gadopentate dimeglumine and fat-suppression technique, American Journal of Neuroradiology, 11, 749 Adam, 1990, Gadolinium-DTPA-enhanced MRI of intraocular tumours, Magnetic Resonance Imaging, 8, 683, 10.1016/0730-725X(90)90002-J Barakos, 1991, Orbit, skull base and pharynx: contrast-enhanced fat-suppression MR imaging, Radiology, 179, 191, 10.1148/radiology.179.1.2006277 Hudgins, 1993, Efficacy and safety of gadopentetate dimeglumine in the evaluation of the extracranial head and neck, Journal of Magnetic Resonance Imaging, 3, 345, 10.1002/jmri.1880030209 Laine, 1990, Perineural tumour extension through the foramen ovale: evaluation with MR imaging, Radiology, 174, 65, 10.1148/radiology.174.1.2152985 Mark, 1993, 14, 37 Bergeron, 1991, The temporal bone, 925 Bobman, 1991, Postoperative lumbar spine: contrast-enhanced chemical shift MR imaging, Radiology, 179, 557, 10.1148/radiology.179.2.2014311 Ross, 1989, Gadolinium-DTPA-enhanced MR imaging of the postoperative lumbar spine: time-course and mechanism of enhancement, American Journal of Roentgenology, 152, 825, 10.2214/ajr.152.4.825 Johnson, 1990, Benign lumbar arachnoiditis: MR imaging with gadopentetate dimeglumine, American Journal of Neuroradiology, 110, 763 Ginsberg, 1994, Contrast enhancement in meningeal and extra-axial disease, Neuroimaging Clinics in North America, 4, 133 Sze, 1988, Intramedullary disease of the spine: diagnosis using gadolinium-DTPA-enhanced MR imaging, American Journal of Roentgenology, 151, 1193, 10.2214/ajr.151.6.1193 Rahmouni, 1993, Lymphoma: monitoring tumor size and signal intensity with MR imaging, Radiology, 188, 445, 10.1148/radiology.188.2.8327695 Funari, 1991, Cardiac tumours: assessment with Gd-DTPA enhanced MR imaging, Journal of Computer Assisted Tomography, 15, 953, 10.1097/00004728-199111000-00009 de Roos, 1989, Reperfused and nonreperfused myocardial infarctions: diagnostic potential of Gd-DTPA-enhanced MR imaging, Radiology, 172, 717, 10.1148/radiology.172.3.2772179 Lauerma, 1994, The use of contrast-enhanced magnetic resonance imaging to define ischemic injury after reperfusion, Investigative Radiology, 29, 527, 10.1097/00004424-199405000-00001 Kopans, 1992, The positive predictive value of mammography, American Journal of Roentgenology, 158, 521, 10.2214/ajr.158.3.1310825 Harms, 1993, MR imaging of the breast, Journal of Magnetic Resonance Imaging, 3, 277, 10.1002/jmri.1880030139 Kerslake, 1995, Dynamic gradient-echo and fat suppressed spin-echo contrast-enhanced MRI of the breast, Clinical Radiology, 50, 440, 10.1016/S0009-9260(05)83159-9 Fobben, 1995, Breast MR imaging with commercially available techniques: radiologic-pathologic correlation, Radiology, 196, 143, 10.1148/radiology.196.1.7784558 Heywang-Koebrunner, 1994, Contrast-enhanced magnetic resonance imaging of the breast, Investigative Radiology, 29, 94, 10.1097/00004424-199401000-00019 Heywang, 1990, Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants, Journal of Computer Assisted Tomography, 14, 348, 10.1097/00004728-199005000-00005 Fretz, 1990, Detection of hepatic metastases: comparsion of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging, American Journal of Roentgenology, 155, 763, 10.2214/ajr.155.4.2119106 Ros, 1995, Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions, Radiology, 196, 481, 10.1148/radiology.196.2.7617864 Semelka, 1992, Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-supressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T, Radiology, 184, 687, 10.1148/radiology.184.3.1324509 Soyer, 1993, MRI of liver metastases from colorectal cancer vs. CT during arterial portography, Journal of Computer Assisted Tomography, 17, 67, 10.1097/00004728-199301000-00012 Hagspiel, 1995, Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US, Radiology, 196, 471, 10.1148/radiology.196.2.7617863 McFarland, 1994, Hepatic hemangiomas and malignant tumours: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging, Radiology, 193, 43, 10.1148/radiology.193.1.8090920 Semelka, 1994, Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images, Radiology, 192, 401, 10.1148/radiology.192.2.8029404 Hamm, 1990, Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging, Journal of Computer Assisted Tomography, 14, 205, 10.1097/00004728-199003000-00009 Mitchell, 1994, Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging, Radiology, 193, 49, 10.1148/radiology.193.1.8090921 Vogl, 1994, Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen, Fortschritte auf dem Gebiet der Röntgenstrahlen, 160, 319, 10.1055/s-2008-1032431 Rofsky, 1993, Hepatocellular tumours: characterization with Mn-DPDP-enhanced MR imaging, Radiology, 188, 53, 10.1148/radiology.188.1.8390072 Hahn, 1988, MR imaging of focal splenic tumours, American Journal of Roentgenology, 150, 823, 10.2214/ajr.150.4.823 Weissleder, 1989, The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide, American Journal of Roentgenology, 152, 175, 10.2214/ajr.152.1.175 Vellet, 1992, Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T, Radiology, 183, 87, 10.1148/radiology.183.1.1312736 Semelka, 1993, Islet cell tumours: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression, Radiology, 186, 799, 10.1148/radiology.186.3.8381551 Gehl, 1993, Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience, Radiology, 186, 795, 10.1148/radiology.186.3.8430190 Haustein, 1992, Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure, Investigative Radiology, 27, 153, 10.1097/00004424-199202000-00012 Semelka, 1992, Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques, Radiology, 182, 425, 10.1148/radiology.182.2.1732961 Semelka, 1993, Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging, Journal of Magnetic Resonance Imaging, 3, 597, 10.1002/jmri.1880030408 Kim, 1993, Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients, Journal of Computer Assisted Tomography, 17, 633, 10.1097/00004728-199307000-00022 Prayer, 1993, CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer, Journal of Computer Assisted Tomography, 17, 626, 10.1097/00004728-199307000-00021 Kim, 1994, Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging, Radiology, 193, 239, 10.1148/radiology.193.1.8090898 Thurnher, 1992, MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images, American Journal of Roentgenology, 159, 1243, 10.2214/ajr.159.6.1442393 Hricak, 1991, Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging, Radiology, 181, 95, 10.1148/radiology.181.1.1887062 Yamashita, 1992, Carcinoma of the cervix: dynamic MR imaging, Radiology, 182, 643, 10.1148/radiology.182.3.1535875 Thurnher, 1990, Gadolinium-DOTA enhanced MR imaging of adnexal tumours, Journal of Computer Assisted Tomography, 14, 939, 10.1097/00004728-199011000-00014 Anderson, 1994, MR imaging of Crohn disease: use of Perflubron as a gastrointestinal contrast agent, Journal of Magnetic Resonance Imaging, 4, 491, 10.1002/jmri.1880040342 Semelka, 1991, Bowel disease: prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences, Journal of Magnetic Resonance Imaging, 1, 625, 10.1002/jmri.1880010603 Prince, 1993, Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography, Journal of Magnetic Resonance Imaging, 3, 877, 10.1002/jmri.1880030614 Prince, 1994, Gadolinium-enhanced MR aortography, Radiology, 191, 155, 10.1148/radiology.191.1.8134563 Lossef, 1992, Gadolinium-enhanced magnitude contrast MR angiography of popliteal and tibial arteries, Radiology, 184, 349, 10.1148/radiology.184.2.1620827 Kransdorf, 1993, Imaging of soft tissue tumours, Radiologic Clinics of North America, 31, 359, 10.1016/S0033-8389(22)02862-7 Mirowitz, 1992, Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI, Journal of Computer Assisted Tomography, 16, 120 Benedikt, 1994, MR imaging of soft-tissue masses: role of gadopentetate dimeglumine, Journal of Magnetic Resonance Imaging, 4, 485, 10.1002/jmri.1880040341 Jones, 1993, Synovial sarcoma: MR imaging findings in 34 patients, American Journal of Roentgenology, 161, 827, 10.2214/ajr.161.4.8396848 Berquist, 1993, Magnetic resonance imaging of primary skeletal neoplasms, Radiologic Clinics of North America, 31, 411, 10.1016/S0033-8389(22)02865-2 Seeger, 1991, Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging, American Journal of Roentgenology, 157, 347, 10.2214/ajr.157.2.1853820 Schima, 1994, Preoperative staging of osteosarcoma: efficacy of MR imaging in detecting joint involvement, American Journal of Roentgenology, 163, 1171, 10.2214/ajr.163.5.7976895 Fletcher, 1992, Pediatric musculoskeletal tumours: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy, Radiology, 184, 243, 10.1148/radiology.184.1.1319075 Erlemann, 1993, Dynamic, gadolinium-enhanced MR imaging to monitor response to chemotherapy (letter), Radiology, 186, 904, 10.1148/radiology.186.3.8430208 Vanel, 1994, MR imaging in the follow-up of malignant and aggressive soft-tissue tumours: results of 511 examinations, Radiology, 190, 263, 10.1148/radiology.190.1.8259417 Koenig, 1990, Rheumatoid arthritis; evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA, Radiology, 176, 473, 10.1148/radiology.176.2.2367663 Herve-Somma, 1992, Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTA, Radiology, 182, 93, 10.1148/radiology.182.1.1727317 Neuhold, 1994, Rheumatoide Arthritis des kraniozervikalen Übergangs, Radiologe, 34, 762 Kramer, 1994, Postcontrast MR arthrography in assessment of cartilage lesions, Journal of Computer Assisted Tomography, 18, 218, 10.1097/00004728-199403000-00009 Kramer, 1992, MR contrast arthrography (MRA) in osteochondrosis dissecans, Journal of Computer Assisted Tomography, 16, 254, 10.1097/00004728-199203000-00014 Chandnani, 1993, Glenoid labral tears: prospective evaluation with MR imaging, MR arthrography, and CT arthrography, American Journal of Roentgenology, 161, 1229, 10.2214/ajr.161.6.8249731